(S)-naringenin increases expression EXP 6480464 naringenin results in increased expression of ARHGDIA mRNA, naringenin results in increased expression of ARHGDIA protein CTD PMID:27838343 (Z)-3-butylidenephthalide increases expression EXP 6480464 butylidenephthalide results in increased expression of ARHGDIA protein CTD PMID:23770345 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ARHGDIA mRNA CTD PMID:15159206 , PMID:15757668 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1552296 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARHGDIA mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1359547 6480464 Tetrachlorodibenzodioxin affects the expression of ARHGDIA mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552296 6480464 Tetrachlorodibenzodioxin affects the expression of ARHGDIA mRNA CTD PMID:24680724 2,4-dinitrotoluene affects expression ISO RGD:1359547 6480464 2, 4-dinitrotoluene affects the expression of ARHGDIA mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:1359547 6480464 2, 6-dinitrotoluene affects the expression of ARHGDIA mRNA CTD PMID:21346803 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of ARHGDIA mRNA CTD PMID:12419474 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of ARHGDIA mRNA CTD PMID:23724009 ampicillin increases expression EXP 6480464 Ampicillin results in increased expression of ARHGDIA mRNA CTD PMID:21632981 arachidonic acid increases expression EXP 6480464 Arachidonic Acid results in increased expression of ARHGDIA mRNA CTD PMID:16704987 bathocuproine disulfonic acid multiple interactions EXP 6480464 [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of ARHGDIA mRNA CTD PMID:15477007 beauvericin decreases expression EXP 6480464 beauvericin results in decreased expression of ARHGDIA mRNA CTD PMID:29203277 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ARHGDIA mRNA CTD PMID:20106945 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of ARHGDIA 3' UTR, Benzo(a)pyrene results in increased methylation of ARHGDIA 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of ARHGDIA promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 Methionine inhibits the reaction [Benzo(a)pyrene results in increased expression of ARHGDIA protein] CTD PMID:22138271 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ARHGDIA protein CTD PMID:22138271 benzo[a]pyrene multiple interactions ISO RGD:1552296 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to ARHGDIA promoter] CTD PMID:19654925 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of ARHGDIA mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:1359547 6480464 bisphenol A results in increased expression of ARHGDIA mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1359547 6480464 bisphenol A results in decreased expression of ARHGDIA mRNA CTD PMID:33296240 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ARHGDIA mRNA CTD PMID:30903817 bortezomib decreases expression EXP 6480464 Bortezomib results in decreased expression of ARHGDIA mRNA CTD PMID:20977926 busulfan multiple interactions EXP 6480464 ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein] CTD PMID:17264767 busulfan affects response to substance EXP 6480464 ARHGDIA mRNA affects the susceptibility to Busulfan CTD PMID:17264767 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of ARHGDIA mRNA, Cadmium results in increased expression of ARHGDIA protein CTD PMID:16440303 , PMID:24376830 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of ARHGDIA mRNA, Cadmium Chloride results in decreased expression of ARHGDIA protein CTD PMID:12760830 , PMID:26220685 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ARHGDIA protein CTD PMID:16440303 , PMID:24527689 choline multiple interactions ISO RGD:1552296 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGDIA mRNA CTD PMID:20938992 choline multiple interactions ISO RGD:1359547 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ARHGDIA protein CTD PMID:19566968 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ARHGDIA mRNA CTD PMID:27392435 , PMID:27594783 cisplatin multiple interactions EXP 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of ARHGDIA mRNA], jinfukang promotes the reaction [Cisplatin results in decreased expression of ARHGDIA mRNA] CTD PMID:27392435 copper atom decreases expression ISO RGD:1552296 6480464 Copper results in decreased expression of ARHGDIA protein CTD PMID:23882024 copper(0) decreases expression ISO RGD:1552296 6480464 Copper results in decreased expression of ARHGDIA protein CTD PMID:23882024 coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA CTD PMID:19167446 CU-O LINKAGE decreases expression ISO RGD:1552296 6480464 cupric oxide analog results in decreased expression of ARHGDIA protein CTD PMID:23882024 daidzein decreases expression EXP 6480464 daidzein results in decreased expression of ARHGDIA mRNA CTD PMID:15757668 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of ARHGDIA protein CTD PMID:31675489 desferrioxamine B decreases expression EXP 6480464 Deferoxamine results in decreased expression of ARHGDIA protein CTD PMID:19515424 desferrioxamine B multiple interactions EXP 6480464 ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of ARHGDIA protein] CTD PMID:19515424 dibutyl phthalate increases expression ISO RGD:1359547 6480464 Dibutyl Phthalate results in increased expression of ARHGDIA mRNA CTD PMID:21266533 dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of ARHGDIA mRNA CTD PMID:28302478 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of ARHGDIA mRNA CTD PMID:15159206 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of ARHGDIA mRNA CTD PMID:15766595 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of ARHGDIA mRNA CTD PMID:17175027 doxorubicin multiple interactions EXP 6480464 ARHGDIA mRNA affects the reaction [Doxorubicin results in increased activity of CASP3 protein] CTD PMID:17264767 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ARHGDIA mRNA CTD PMID:29803840 doxorubicin affects response to substance EXP 6480464 ARHGDIA mRNA affects the susceptibility to Doxorubicin CTD PMID:17264767 elemental selenium increases expression EXP 6480464 Selenium results in increased expression of ARHGDIA mRNA CTD PMID:19244175 endosulfan increases expression ISO RGD:1359547 6480464 Endosulfan results in increased expression of ARHGDIA mRNA CTD PMID:29391264 Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA CTD PMID:19167446 estriol decreases expression EXP 6480464 Estriol results in decreased expression of ARHGDIA mRNA CTD PMID:15159206 estrone decreases expression EXP 6480464 Estrone results in decreased expression of ARHGDIA mRNA CTD PMID:15159206 ethanol increases expression ISO RGD:1552296 6480464 Ethanol results in increased expression of ARHGDIA mRNA CTD PMID:19167417 ethanol affects splicing ISO RGD:1552296 6480464 Ethanol affects the splicing of ARHGDIA mRNA CTD PMID:30319688 ethanol decreases expression ISO RGD:1359547 6480464 Ethanol results in decreased expression of ARHGDIA protein CTD PMID:23702218 ethyl methanesulfonate decreases expression EXP 6480464 Ethyl Methanesulfonate results in decreased expression of ARHGDIA mRNA CTD PMID:23649840 ferric ammonium citrate multiple interactions EXP 6480464 ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of ARHGDIA protein] CTD PMID:19515424 fipronil decreases expression ISO RGD:1359547 6480464 fipronil results in decreased expression of ARHGDIA mRNA CTD PMID:23962444 flutamide increases expression ISO RGD:1359547 6480464 Flutamide results in increased expression of ARHGDIA mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1552296 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGDIA mRNA CTD PMID:20938992 folic acid multiple interactions ISO RGD:1359547 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ARHGDIA protein CTD PMID:19566968 folic acid increases expression ISO RGD:1552296 6480464 Folic Acid results in increased expression of ARHGDIA mRNA CTD PMID:25629700 fumonisin B1 increases expression ISO RGD:1552296 6480464 fumonisin B1 results in increased expression of ARHGDIA mRNA CTD PMID:16221962 genistein decreases expression EXP 6480464 Genistein results in decreased expression of ARHGDIA mRNA CTD PMID:15159206 , PMID:15757668 glycitein decreases expression EXP 6480464 glycitein results in decreased expression of ARHGDIA mRNA CTD PMID:15757668 heparin increases expression ISO RGD:1359547 6480464 Heparin results in increased expression of ARHGDIA protein CTD PMID:17488504 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of ARHGDIA mRNA CTD PMID:12419474 hydroquinone affects expression EXP 6480464 hydroquinone affects the expression of ARHGDIA protein CTD PMID:17181942 ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of ARHGDIA protein CTD PMID:32959892 L-ascorbic acid increases expression ISO RGD:1552296 6480464 Ascorbic Acid results in increased expression of ARHGDIA mRNA CTD PMID:22139585 L-glutamic acid decreases expression ISO RGD:1359547 6480464 Glutamic Acid results in decreased expression of ARHGDIA mRNA CTD PMID:25797319 L-methionine multiple interactions EXP 6480464 Methionine inhibits the reaction [Benzo(a)pyrene results in increased expression of ARHGDIA protein] CTD PMID:22138271 L-methionine multiple interactions ISO RGD:1359547 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ARHGDIA protein CTD PMID:19566968 L-methionine multiple interactions ISO RGD:1552296 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGDIA mRNA CTD PMID:20938992 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of ARHGDIA mRNA CTD PMID:19921347 lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of ARHGDIA mRNA CTD PMID:19921347 lovastatin increases expression ISO RGD:1552296 6480464 Lovastatin results in increased expression of ARHGDIA mRNA CTD PMID:20493250 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of ARHGDIA mRNA CTD PMID:17175027 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of ARHGDIA mRNA CTD PMID:17175027 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of ARHGDIA mRNA CTD PMID:17175027 methamphetamine increases expression ISO RGD:1359547 6480464 Methamphetamine results in increased expression of ARHGDIA protein CTD PMID:19826936 methotrexate affects response to substance EXP 6480464 ARHGDIA protein affects the susceptibility to Methotrexate CTD PMID:16217747 nickel atom increases expression EXP 6480464 Nickel results in increased expression of ARHGDIA mRNA CTD PMID:24768652 , PMID:25583101 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of ARHGDIA mRNA CTD PMID:15159206 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of ARHGDIA mRNA CTD PMID:17762391 paclitaxel multiple interactions EXP 6480464 ARHGDIA mRNA affects the reaction [Paclitaxel results in increased activity of CASP3 protein] CTD PMID:17264767 paclitaxel affects response to substance EXP 6480464 ARHGDIA mRNA affects the susceptibility to Paclitaxel CTD PMID:17264767 paracetamol affects expression ISO RGD:1552296 6480464 Acetaminophen affects the expression of ARHGDIA mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ARHGDIA mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:1552296 6480464 Acetaminophen results in increased expression of ARHGDIA mRNA CTD PMID:29246445 paracetamol multiple interactions ISO RGD:1552296 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of ARHGDIA mRNA] CTD PMID:29246445 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ARHGDIA mRNA CTD PMID:22230336 paraoxon increases expression EXP 6480464 Paraoxon results in increased expression of ARHGDIA protein CTD PMID:20931991 pentachlorophenol increases expression ISO RGD:1552296 6480464 Pentachlorophenol results in increased expression of ARHGDIA mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1552296 6480464 perfluorooctane sulfonic acid results in decreased expression of ARHGDIA protein CTD PMID:26178269 phenobarbital multiple interactions ISO RGD:1552296 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ARHGDIA mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:1552296 6480464 Phenobarbital results in increased expression of ARHGDIA mRNA CTD PMID:19482888 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of ARHGDIA mRNA CTD PMID:18070364 pyrogallol increases expression ISO RGD:1552296 6480464 Pyrogallol results in increased expression of ARHGDIA mRNA CTD PMID:20362636 pyrrolidine dithiocarbamate decreases expression EXP 6480464 pyrrolidine dithiocarbamic acid results in decreased expression of ARHGDIA mRNA CTD PMID:15477007 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of ARHGDIA mRNA CTD PMID:15477007 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of ARHGDIA mRNA CTD PMID:25667456 selenium atom increases expression EXP 6480464 Selenium results in increased expression of ARHGDIA mRNA CTD PMID:19244175 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ARHGDIA mRNA CTD PMID:28595984 , PMID:34032870 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ARHGDIA mRNA CTD PMID:12760830 sodium dichromate decreases expression ISO RGD:1359547 6480464 sodium bichromate results in decreased expression of ARHGDIA mRNA, sodium bichromate results in decreased expression of ARHGDIA protein CTD PMID:21437922 Soman increases expression ISO RGD:1359547 6480464 Soman results in increased expression of ARHGDIA mRNA CTD PMID:19281266 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of ARHGDIA mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of ARHGDIA mRNA CTD PMID:12419474 tetrachloromethane increases expression ISO RGD:1552296 6480464 Carbon Tetrachloride results in increased expression of ARHGDIA mRNA CTD PMID:31919559 thalidomide increases expression ISO RGD:1552296 6480464 Thalidomide results in increased expression of ARHGDIA mRNA CTD PMID:26217789 thioacetamide increases expression ISO RGD:1359547 6480464 Thioacetamide results in increased expression of ARHGDIA mRNA CTD PMID:34492290 triacsin C increases expression EXP 6480464 triacsin C results in increased expression of ARHGDIA mRNA CTD PMID:16704987 tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of ARHGDIA mRNA CTD PMID:29453283 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ARHGDIA mRNA CTD PMID:23179753 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ARHGDIA mRNA CTD PMID:25979313 vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of ARHGDIA mRNA CTD PMID:19244175 warfarin increases expression ISO RGD:1552296 6480464 Warfarin results in increased expression of ARHGDIA mRNA CTD PMID:20493250 WIN 55212-2 decreases expression ISO RGD:1552296 6480464 (3R)-((2 more ... CTD PMID:12237329 zoledronic acid decreases expression EXP 6480464 zoledronic acid results in decreased expression of ARHGDIA protein CTD PMID:28871336